All Quotes

I sincerely hope that the United States and the international community will rise to the occasion of this historic moment.

Burma is now being controlled by a ruthless brutal illegal military junta.

Prohibitively higher.

It is not only higher, it is massively higher.

The problem is the bankers or the people that finance, they want their money back, maybe not in three years, but they want it back in sooner than 40 years.

I appreciate that, and that is why I emphasized that I think demonstration projects, R&D, additional support for the new technologies that can bring that cost down.

Nuclear power just is not remotely competitive economically in terms of new plants.

They essentially discriminate against any capital-intensive energy farm. They make natural gas pretty much the only alternative.

Let me just say that I recognize this is a local and state decision, but the signals you send, the guidance you provide will be very influential.

I am concerned that San Diego, under your leadership, has closed its schools for in-person instruction this year.

I think this is an area that cries out for reform.

How should Congress ensure that we are recognizing innovative science versus rewarding an innovative legal strategy that is simply designed to block more affordable competitors by gaming the patent system?

Even though there are several biosimilars for the best-selling drug in the world, Humira, and they've been on the market in the European Union since 2018, American patients must wait another two years for them to be available here due to…

I also worked with Senator Bob Casey to investigate various entities in the opaque market for pricing of prescription drugs.

Later this spring, along with my colleague Senator Tim Kaine, I will reintroduce the Biologic Patent Transparency Act to prevent drug manufacturers from gaming the patent system.

I led a bipartisan investigation with then-Senator Claire McCaskill of Missouri on sudden price spikes of off-patent drugs.

I think we're in the early innings of what will become an evolving set of tools that many innovator drug companies may engage with to protect their assets, and this runs completely counter to the objectives of competition for biosimilars…

As co-chairs of the Senate Diabetes Caucus, which I founded in 1998, Senator Jeanne Shaheen and I introduced legislation in the last Congress to create a new pricing model for insulin.